Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Nature
|
December 13, 2002
The Molecule Pages database
Joshua Li, Yuhong Ning, Warren Hedley, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2024
Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non-small cell lung cancer
Gulfem D Guler, Yuhong Ning, Ceyda Coruh, et al.
Plos One
|
February 4, 2010
A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines
Paul W Hollenbach, Aaron N Nguyen, Helen Brady, et al.
Frontiers in Immunology
|
May 4, 2013
Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy
Lin Kang, Vanessa Voskinarian-Berse, Eric Law, et al.
British Journal of Haematology
|
December 17, 2013
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.)
Anita K Gandhi, Jian Kang, Courtney G Havens, et al.
Molecular Cancer Therapeutics
|
June 6, 2018
Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G<sub>1</sub>-S Checkpoint
Dan Zhu, Shuichan Xu, Gordafaried Deyanat-Yazdi, et al.
Nature Communications
|
October 20, 2020
Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA
Gulfem D Guler, Yuhong Ning, Chin-Jen Ku, et al.
British Journal of Haematology
|
February 26, 2016
Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myeloma
Emily Rychak, Derek Mendy, Tao Shi, et al.
Communications Biology
|
November 19, 2025
5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNA
Yuan Xue, Yuhong Ning, Verena Friedl, et al.
Nature Communications
|
December 3, 2020
A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation
Xiao-Long Cui, Ji Nie, Jeremy Ku, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Nature
|
December 13, 2002
The Molecule Pages database
Joshua Li, Yuhong Ning, Warren Hedley, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2024
Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non-small cell lung cancer
Gulfem D Guler, Yuhong Ning, Ceyda Coruh, et al.
Plos One
|
February 4, 2010
A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines
Paul W Hollenbach, Aaron N Nguyen, Helen Brady, et al.
Frontiers in Immunology
|
May 4, 2013
Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy
Lin Kang, Vanessa Voskinarian-Berse, Eric Law, et al.
British Journal of Haematology
|
December 17, 2013
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.)
Anita K Gandhi, Jian Kang, Courtney G Havens, et al.
Molecular Cancer Therapeutics
|
June 6, 2018
Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G<sub>1</sub>-S Checkpoint
Dan Zhu, Shuichan Xu, Gordafaried Deyanat-Yazdi, et al.
Nature Communications
|
October 20, 2020
Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA
Gulfem D Guler, Yuhong Ning, Chin-Jen Ku, et al.
British Journal of Haematology
|
February 26, 2016
Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myeloma
Emily Rychak, Derek Mendy, Tao Shi, et al.
Communications Biology
|
November 19, 2025
5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNA
Yuan Xue, Yuhong Ning, Verena Friedl, et al.
Nature Communications
|
December 3, 2020
A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation
Xiao-Long Cui, Ji Nie, Jeremy Ku, et al.
Page
of 2